Cellino Biotech, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2042
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 20, 2026The maintenance fee for Platforms and Systems for Automated Cell Culture (US 11,680,247) comes due Dec 20, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due Jan 25, 2027The maintenance fee for Platforms and systems for automated cell culture (US 11,708,563) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
- 1 fee due Jul 9, 2027The maintenance fee for Platforms and Systems for Automated Cell Culture (US 11,866,735) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
- 1 fee due Aug 27, 2027The maintenance fee for Platforms and Systems for Automated Cell Culture (US 11,913,029) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
- 1 fee due Sep 19, 2027The maintenance fee for Platforms and systems for automated cell culture (US 11,931,737) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,680,247 | Platforms and Systems for Automated Cell Culture In force · High confidence | In force | High confidence | |
| US 11,708,563 | Platforms and systems for automated cell culture In force · From the USPTO record | In force | From the USPTO record | |
| US 11,866,735 | Platforms and Systems for Automated Cell Culture In force · High confidence | In force | High confidence | |
| US 11,913,029 | Platforms and Systems for Automated Cell Culture In force · High confidence | In force | High confidence | |
| US 12,173,327 | Platforms and systems for automated cell culture In force · From the USPTO record | In force | From the USPTO record | |
| US 12,195,765 | Platforms and Systems for Automated Cell Culture In force · High confidence | In force | High confidence | |
| US 11,643,667 | Microfluidic Laser-Activated Intracellular Delivery Systems and Methods In force · High confidence | In force | High confidence | |
| US 12,344,855 | Systems for Cell Control In force · High confidence | In force | High confidence | |
| US 11,931,737 | Platforms and systems for automated cell culture In force · From the USPTO record | In force | From the USPTO record | |
| US 12,472,496 | Platforms and systems for automated cell culture In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
9 pending · 1 abandoned · 3 no status recorded